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Werner Syndrome is a rare autosomal recessive disorder 
characterized by an increased cancer risk and by symptoms 
suggestive of premature aging. Cells from these patients 
demonstrate a typical pattern of chromosomal instability and 
a spontaneous hypermutability with a high rate of unusually 
large deletions. We have studied the in vivo DNA ligation in 
three lymphoblast cell lines from Werner syndrome patients 
and three from normal donors. In our host cell ligation assay 
we transfected linearized plasmid pZ189 and measured the 
amount of plasmid DNA ends rejoined by these host cells as 
the ability of the recovered plasmid to transform bacteria. A 
mutagenesis marker gene close to the ligation site allowed 
screening for mutations. Subsequent mutation analysis pro-
vided information about the accuracy of the ligation process. 
The cells from Werner syndrome patients were as effective as 
Patients with the rare autosomal recessive disorder Werner syndrome exhibit several clinical features sug-gestive of premature aging in early adulthood (e.g., bi-lateral cataracts, greying of the hair, alopecia, ar-teriosclerosis, osteoporosis, diabetes mellitus, thin 
extremities, scleroderma-like skin changes, and trophic ulcers of the 
legs) [1-4]. An increased risk to develop various neoplasms includ-
ing different types of carcinomas and sarcomas, is well established 
[5-7]. 
Cultured fibroblasts from patients with Werner syndrome are 
characterized by a reduced replicative life span [8] . Because of an 
increased spontaneous chromosome breakage, structural chromo-
some abnormalities, and a "variegated translocation mosaicism," 
Werner syndrome has been termed a chromosome instability syn-
drome [9 -12]. Because of increased spontaneous mutation fre-
quency, Werner syndrome has also been termed a mutator syn-
drome [13,14]. The chromosome instability and mutator phenotype 
are thought to be responsible for the progeroid features and the 
increased cancer risk in affected patients. Characterization of spon-
taneous mutations revealed an unusually high rate oflarge deletions 
[15]. The Werner syndrome gene has been mapped to 8p12 [1 6, 17], 
the same location as the gene encoding for DNA polymerase p, but 
the underlying molecular defect in Werner syndrome has not been 
identified. No DNA repair defect has been found [18,19]. 
Previously, we reported abnormal ligation of DNA ends from 
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normal cells in ligating DNA ends. However, mutation 
analysis revealed that the three Werner syndrome cell lines 
introduced 2.4-4.6 times more mutations (p < 0.001) thall 
the normal cell lines during ligation of the DNA ends: the 
mutation rates were 69.4, 97.2, and 58.7%, as compared to 
23.6, 21.7, and 24.4% in the normal cell lines. These in-
creased mutation frequencies in plasmids ligated during pas-
sage through Werner syndrome cells were mainly due to a 
significant (p < 0.001) increase in deletions. This error-
prone DNA ligation might be responsible for the spontane-
ous hypermutability and the genomic instability in Werner 
syndrome cells and related to the apparently accelerated 
aging and high cancer risk in affected patients. Key words: host 
cell ligation assay/chromosome instability / mutagel1esis/plasmid 
vector.] Invest DermatoI102:45-48, 1994 
transfected plasmids in cells from three cancer-prone, classic chro-
mosome breakage disorders, Bloom syndrome, ataxia telangiectasia, 
and Fanconi anemia [20 - 22]. We have now used the same host cell 
ligation assay to study the efficiency and the accuracy of the DNA 
ligation process in lymphoblasts from three patients with Werner 
syndrome. In this assay, linearized plasmid pZ189 is transfected into 
the lymphoblast host cells and subsequently ligated by cellular en-
zymes. After 3 d the replicated plasmid is recovered and used to 
transform bacteria. Because only circular plasmids are able to repli-
cate, each bacterial colony reflects a ligation of plasmid DNA ends 
that occurred during passage through the host cells. Scorin.g of 
bacterial colonies thus facilitates the assessment of the host cell's 
DNA ligation efficiency. In addition, mutation analysis of reCOV-
ered ligated plasmids allows assessment of the accuracy of the DNA 
ligation process. 
MATERIALS AND METHODS 
Cells Epstein-Barr virus - transformed lymphoblast cell lines from normal 
donors (GM3715, GM0621, and GM0130) were obtained from the Human 
Genetic Cell Repository (Camden, NJ). The lymphoblast cell lines UJ and 
KY from patients with W erner syndrome were obtained from Dr. O. Ni-
kaido in 1984. The cell line WSI0l was established by Epstein-Barr virus 
transformation of peripheral blood mononuclear cells from a Werner syn-
drome homozygote, investigated by Dr. Y. Fujiwara. All three patients were 
Japanese. The cells were grown in RPMI 1640 medium supplemented with 
17% fetal bovine serum and 2 mM L-glutamine at 37"C and 5% CO2 .The 
cells were transfected at exponential growth phase. Viability, as determined 
by trypan blue exclusion, was above 85%. Mean doubling times were 52 h 
with GM3715, 68 h with GM0621, 59 h with GM0130, 57 h with UJ, 40 h 
with WS101, and 59 h with KY. 
Plasmid Assay The 5.5-kbp replicating SV40-based shuttle vector plas-
mid pZ 189 was prepared, transfected, and recovered as described in detail 
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previously [22]. This plasmid contains the bacterial mutagenesis marker 
gene St.pF adjacent to a single EwR I restriction site and the bacterial gene for 
ampicill in resistance. Linear plasmid was prepared by c1eav~ge with the 
restriction endonuclease EcoR I at bp 1. Complete IlIleanzauon (less than 
0.05% of circular forms remaining) was verified by agarose gel electropho-
resis and Southern blotting. For electrotransformation we used the gene 
pulser apparatus and capacitance extender (Bio-Rad): 15 X 106 1ymphoblasts 
in a 0.4 ml suspension wi th 5 J1.g of linear or circular plasmid in serum-free 
RPMI 1640 medium were submitted once to an electrical pulse (250 V, 960 
J1.FD capacitor, time constant between 20 and 30 mseconds) at room temper-
ature in an electrode cuvette with an interelectrode distance 0[0.4 cm and 
then transferred to 20 ml of prewarmed complete medium. Replicated plas-
mids recove red after 3 d were subsequently introduced by electrotransfor-
mation (interelectrode distance 0.2 cm, total volume 80 J1.l, 2500 V, 25 J1.Fd 
capaci ror, 600 Ohms resistance, time constant 8-15 mseconds) into Esclle-
riclria co li MBM7070, which contains a suppressable mutation in the gene for 
p-galactosidase. The bacteria were plated on LB agar dishes containing am-
pici llin, the indicator dye X-gal (5-bromo-4-chloro-3-indolyl-p-D-galacto-
side), and the inducer of p-galactosidase, isopropyl-p-D-galactoside (lPTG). 
At least three independent bacterial transformations were performed with 
every recovered plasmid DNA. 
P lasmid survival was determined by scoring bacterial colonies from repli-
cated plasmids obtained from cells transfected with linear p lasmids and 
dividing by the number of bacterial colonies from parallel samples in the 
same experiment transfected with circular plasmid . This reference sampl e 
with circular plasmid was used in every experiment to compensate for varia-
tions in transfection rates, plasmid replication, or condition of the cells used. 
The survival rates from several bacterial transformations in several indepen-
dent experiments were then averaged. 
A representative sample of plasmids from blue, light blue, and white 
bacterial colonies was analyzed. The color change from blue to light blue or 
white indicates partial or complete inactivation of the mutagenesis target 
gene sHpF, located close to the ligation site. Using agarose gel electrophore-
sis, we compared the size of purified plasmids to the size of the wild-type 
plasmid. We tested for conservation of the EeaR I restriction site by redigest-
ing with this enzyme. A successful cleavage indicates that not a single base 
pair was deleted during the ligation process. Th is fac ilitates mutation ana ly-
sis on the base sequence level without DNA sequencing of every recovered 
mutant. Our previously described, 98% accurate mutant classification 
scheme, which is based on our experience with sequencing of recovered 
mutants [20,22], allows identification of unchanged pl asmids and classifica-
tion of mutants into three categories: a) deletions at the ligation site, b) 
insertions or more complex mutations at the ligation site, or c) point muta-
tions in the adjacent slIpF mutagenesis marker gene. 
The mutation frequency was calculated separately for the blue and the 
light blue or white colonies, added for each independent sample, and aver-
aged. The mutation analysis for blue colonies was assessed by the analysis of 
plasm ids purified from blue colonies as the ratio of number of mutated 
plasmids/total number of analyzed plasmids, and calcu.l ated for each inde-
pendent sample. T he frequency of a particular type of mutation was deter-
mined by multiplying the mutation frequency of blue colonies of each 
independent sample with the frequency of this class of mutation in a repre-
sentative sample of blue colonies. These rates for the blue colonies and the 
similarly calculated rates for the light blue or white colonies were then 
averaged. The Student t test was used to test for differences. The statistical 
analys is of the data was done exactly as previously [20,21 ] with the assistance 
of R. Tarone. 
RESULTS 
Survival of Linear Plasmid (DNA Ligation Efficiency) 
Transformation of bacteria with plasmids recovered after transfec-
tion of linear plasmid into the host cells yielded a mean number of 
1698 colonies/transformation in GM3715, 18473 in GM0 621 , 174 
inGM0 130,405 in UJ, 204 in WS101,and 14 in KY. TableIshows 
the surviva l ofli near plasmid pZ189 after passage through these six 
eel! lines in percent, re lative to the circular control. This su rviva l 
refl ects DNA ligation efficiency to circular plasmid by the host 
cells. 
There was a considerable variation, up to 2.4-times, of DNA 
ligation efficiency in the three normal cell l ines. The survival of 
linear plasmid in the three cell lines [rom patients w ith Werner 
syndrome was not statistically different from the normal cel l lines, 
indicating a normal ligation rate of DNA ends from linear plasmid. 
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Table I. Survival of Linear Plasmid pZ 189 (DNA Ligation 
Efficiency) After Passage Through T hree Lymphoblast Lines , 
from Normal Donors and Three from Werner Syndrome Pati~ 
Cell Line 
GM3715 (normal) 
GM0621 (normal) 
GM0t30 (normal) 
UJ (Werner syndrome) 
WS10l (Werner syndrome) 
KY (Werner syndrome) 
n" 
10 
12 
7 
9 
8 
3 
Plasmid Survival 
{Relative Number of 
Bacterial Colonies)1 \ 
Mean % 
3.5 
4.0 
8 .3 
4.0 
3.2 
3.3 
±SEM 
1.2 
1.0 
2.7 
1.7 
0.9 
1.4 
• Number of independent samples. 
• The relative number of bacterial colonies (percent of circular control) reflects DNA 
ligation efficiency to circular plasmid by [he host cells. 
Mutation Frequency in Recircularized Plasmid (Fidelity of 
DNA Ligation) Figure 1 sh ows the total mutation frequ encies in 
recircularized plasmid pZ 19, ligated during passage through three 
lymphoblast lines from normal donors and three lymphoblas t lines 
from patients with Werner syndrome. The three normal ce ll line. 
demon strated very similar, not statistica lly different mutation fre-
quencies. For example, a mutation frequency of23.6% with the cell 
line GM3715 means that 76.4% of all plasmids ligated in that cell i 
line were ligated absolutely faithfully, without the loss of even a 
single base pair. All three cel l lines from patients w ith Werne! 
syndrome demonstrated a significantly (p < 0.001 for all WerneI 
syndrom e cell lines) increased mutation frequency in recircularized 
plasmids, 2.4 to 4.6 times. These numbers are based on the analysis 
of 508 recircularized plasm ids (45 -155/ceHline) from three to 13 
independent samples/eel! line. For example, the mutation fre· 
quency of97.2% in the Werner syndrome cell line WS101 mea.!1l 
that th ere was almost no DNA ligation w ithout loss of genetic 
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Figure 1. Mutation frequencies in recircularized plasmids pZ189, ligated 
during passage through three lymphoblast lines from normal donors 
(GM3715, GM0621, GMOI30) and three lymphoblast lines from patient! 
with Werner syndrome (Uj, WSI01, KY) . T his renects the accuracy of th~ 
DNA ligation process within these host cells. Error bars, standard deviation. 
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Table II. Frequency of the Types of Mutations Obtained After Ligation of Linear Plasmid pZ189 in Three Lymphoblast Lines from 
Normal Donors and Three from Werner Syndrome Patients 
Deletions at the Insertions or Point Mutations in 
J oin.ing Site Complex Mutations Adjacent stlpF Gene 
Cell Lille n' Il! %±SD' pJ % ±SD' pJ %±SD' pJ 
GM3715 (normal) 12 155 21.0 ± 1.8 
GM0621 (normal) 13 87 17.2 ± 4.2 
GM0130 (normal) 7 107 19.9 ± 3.1 
UJ (Werner syndrome) 9 57 64.2 ± 3.4 < 0.001 
WSI0l (Werner syndrome) 8 57 87.7 ± 1.8 < 0.001 
KY (Werner syndrome) 3 45 50.6 ± 6.8 < 0.001 
1.6 ± 0.3 1.1 ± 0.7 
2.5 ± 0.6 2.1 ± 2.0 
3.5 ± 0.2 1.0 ± 0.9 
3.5 ± 2.8 ns 1.7 ± 1.4 ns 
9.5 ± 2.3 < 0.001 O.O± 0.0 < 0.01 
7.0 ± 5.7 < 0.001 1.0 ± 1.7 ns 
• n, number of independent samples . 
• n, number of recircularized plasmids analyzed. 
, Mutation frequency in % ± SD. 
J p, P value of Student t test, testing for difference from normal cc1l lines; n" not significant. 
information. Tbis data shows a hypermutable, error-prone ligation 
of plasmid DNA ends in the three Werner syndrome lymphoblast 
cell lines, as compared to the three normal cell lines . 
Detailed mutation analysis of recircularized plasmids allowed the 
determination of the frequencies of the different types of mutations, 
as shown in Table II. The deletion at the joining site is the predomi-
nant mutation with all cell lines. The increased total mutation fre-
quency with the Werner syndrome cell lines was almost entirely 
due to a significant (p < 0.001) 2.4- to 5.0-times increase in dele-
tions. The rate of insertions or complex mutations contributed only 
little to the increased total mutation frequencies with two Werner 
syndrome cell lines. 
DISCUSSION 
The data from our host cel l ligation assay indicates a hypermutable 
ligation oflinear plasmid DNA in three lymphoblast cell lines from 
patients with Werner syndrome, mainly due to an increased rate of 
deletions, whereas the overall DNA ligation efficiency was normal . 
These results of an error-prone DNA ligation do not identify a 
specific cellular defect, but might explain some of the features of 
Werner syndrome cells. 
A spontaneous hypermutability with predominantly large dele-
tions has been reported in Werner syndrome [15J. One could specu-
late that an error-prone DNA ligation, e.g. , during the repair of 
spontaneous DNA double-strand breaks, could induce such dele-
tions . This hypothesis is further supported by our finding that the 
hypermutable ligation of tbe DNA ends in Werner syndrome cells 
was mainly characterized by an increased rate of deletions at the 
ligation sites. 
To study mechanisms of spontaneous deletion formation, Mon-
nat et al [23J characterized spontaneous deletions in the human 
hypoxanthine phosphoribosyltransferase gene in 10 Werner syn-
drome patients and 10 patients with myeloic leukemia. They found 
no consistent difference in junction structure between Werner syn-
drome and myeloid leukemia cells and suggested similar or identical 
pathways of deletion formation in Werner syndrome cells and other 
human cells, probably by nonhomologous recombination. Cheng et 
al [24J also used a plasmid assay to study DNA recombination in 
Werner syndrome cells. In three of six fibroblast lines they found an 
elevated recombination frequency. They speculated that an elevated 
recombination frequency could be responsible for the frequent oc-
currence of chromosomal abberrations, or, vice versa, that an in-
creased level of free DNA ends might enhance DNA recombina-
tion. An abnormal DNA ligation of DNA ends cou ld generate more 
free DNA ends within the cells and explain their findings. How-
ever, our result of a normal efficiency of DNA ligation is not con-
sistent with that explanation. 
An abnormal DNA ligation during DNA replication might also 
explain the prolongation of the S-phase ill Werner syndrome fibro-
blasts and lymphoblasts [25,26). 
Patients from the other chromosome breakage syndromes, 
Bloom syndrome, ataxia telangiectasia, and Fanconi anemia suffer 
from an increased cancer risk as well [27 -29). Partially purified 
enzyme fractions from Bloom syndrome cell lines indicated a re-
duced DNA joining activity of a high - molecular-weight DNA 
ligase fraction [30 - 32), but no coding mutations in the DNA ligase 
I gene were found [33J. However, a cell line from a patient with a 
Bloom syndrome-like disorder with a retarded joining of strand 
breaks generated after exposure to DNA-damaging agents was 
shown to have a mutated DNA ligase I gene [34J . 
Earlier, we have studied DNA ligation in cells from such patients 
using our host cell ligation assay. With Bloom syndrome cells we 
found not only a hypermutable, but also a reduced, DNA ligation. 
These results were consistent with, and could be explained by, the 
reduced DNA ligase r activity in these cell lines [20J. With ataxia 
telangiectasia fibroblasts we found a similar impairment of DNA 
ligation, but the spectrum of mutations was different than with 
Bloom syndrome cells [21 J. With Fanconi anemia lymphoblasts we 
found a normal DNA ligation efficiency, like with Werner syn-
drome cells, and an error-prone DNA ligation as well, although 
much less pronounced than with Werner syndrome cells. However, 
the most important difference was that with Fanconi anemia celIs 
the hypermutability was due to an increase in insertions and com-
plex mutations, and not in deletions, as with Werner syndrome cells 
l22J. In summary, we reported an impairment of the ligation of 
plasmid DNA ends in all of the cancer-prone chromosome instabil-
ity syndromes, including in Werner syndrome in this paper, but the 
findings were different in detail. This suggests a pivotal role of an 
accurate DNA ligation in maintaining genetic stability. In Werner 
syndrome the hypermutable DNA ligation might facilitate the loss 
of genetic information during DNA ligation processes, possibly 
representing a novel mechanism of deletion formation during cell 
proliferation. This might be responsible for the genetic instability 
and the high cancer risk in affected patients. 
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